Sulfur dichloride | CAS:10545-99-0

We serve Sulfur dichloride CAS:10545-99-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Sulfur dichloride

Chemical Name:Sulfur dichloride
CAS.NO:10545-99-0
Synonyms:Sulfur dichloride
chlorosulfenyl chloride
sulfurous dichloride
Dichlorosulfane
Dichloro sulfide
 
Physical and Chemical Properties:
Density 1.355 g/mL at 25 °C
Melting Point -80ºC
Molecular Formula Cl2S
Molecular Weight 102.97100
 
Specification:
Appearance:Dark-red liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Carbosulfan(CAS:55285-14-8) and Aminosulfulan(CAS:82560-54-1).



Contact us for information like Sulfur dichloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Dichloro sulfide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Dichloro sulfide Use and application,Dichloro sulfide technical grade,usp/ep/jp grade.


Related News: Both were in Siberia, and both are Chinese nationals who had recently traveled to China.3-Methylquinoline-8-sulfonyl chloride manufacturer Both were in Siberia, and both are Chinese nationals who had recently traveled to China.4-Bromoisobenzofuran-1,3-dione supplier INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.2-(4-bromophenyl)triphenylene vendor Targets within the tumor microenvironment may include both plasma membrane proteins as well as proteins typically secreted into the extracellular space.Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical.